title: [Secondary prevention of ischemic non cardioembolic stroke].
abstract: Stroke patients are at high risk for recurrence or new occurrence of other cardiovascular events or cardiovascular mortality. It is estimated that a high percentage of non-cardioembolic ischemic stroke can be prevented by a suitable modification of lifestyle (diet and exercise), reducing blood pressure (BP) with antihypertensive medication, platelet aggregation inhibitors, statins and high intake reducing consumption of. Unfortunately the degree of control of the different risk factors in secondary prevention of stroke is low. The clinical practice guidelines show clear recommendations with corresponding levels of evidence, but only if implemented in a general way they will get a better primary and secondary stroke prevention.
authors.affiliation: Servicio de Atención Integrada Riesgo Vascular, Hospital Moisés Broggi-Consorci Sanitari Integral, Sant Joan Despí, Barcelona, España; Servicio de Medicina Interna, Hospital Moisés Broggi-Consorci Sanitari Integral, Sant Joan Despí, Barcelona, España. Electronic address: parmario@csi.cat.
authors.forename: Pedro
authors.initials: P
authors.lastname: Armario
authors.affiliation: Tratamiento de la Dislipemia en la Prevención Secundaria del Ictus, Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge, l'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Xavier
authors.initials: X
authors.lastname: Pinto
authors.affiliation: Unidad de Lípidos i Arteriosclerosis, Servicio de Medicina Interna, Hospital de Sta Caterina, Salt, Girona, España.
authors.forename: Cristina
authors.initials: C
authors.lastname: Soler
authors.affiliation: Unidad de Ictus y Enfermedades Cerebrovasculares, Servicio de Neurología, Hospital Universitario de Bellvitge, l'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Pere
authors.initials: P
authors.lastname: Cardona
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors
keywords: Cardiovascular risk factors; Factores de riesgo cardiovacular; Ictus isquémico; Ischaemic stroke; Prevención secundaria ictus; Secondary prevention stroke